Allworth Financial LP

Position in BHC — Bausch Health Companies Inc.

CIK 1555170 FOLSOM, CA

Position in BHC

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$5,886

-$1,944 QoQ

Shares Held

1,194

-17.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#181

of 220 holders

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Allworth Financial LP holds $7,771,550 across 48 Drug Manufacturers - Specialty & Generic names. BHC ranks #31 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	14,853	$2,503,324
2	SUPN	Supernus Pharmaceuticals, Inc.	50,669	$2,356,615
3	UTHR	UNITED THERAPEUTICS Corp	1,167	$632,315
4	ZTS	Zoetis Inc.	6,658	$478,443
5	VTRS	Viatris Inc	18,367	$291,667
6	TAK	Takeda Pharmaceutical Co Ltd	13,516	$216,661
7	ELAN	Elanco Animal Health Inc	8,616	$212,039
8	COLL	Collegium Pharmaceutical, Inc	4,826	$174,701

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,886	1,194	-17.7%	Shares	Sole	2026-08-11
2026-03-31	$7,830	1,450	-22.9%	Shares	Sole	2026-05-15
2025-12-31	$13,072	1,881	+16.4%	Shares	Sole	2026-02-05
2025-09-30	$10,423	1,616	+6.3%	Shares	Sole	2025-12-02
2025-06-30	$10,123	1,520	+7900.0%	Shares	Sole	2025-08-07
2025-03-31	$122	19	-78.2%	Shares	Sole	2025-04-30
2022-09-30	$599	87	-92.0%	Shares	Sole	2022-11-14
2022-06-30	$9,070	1,085	+117.0%	Shares	Sole	2022-07-13
2022-03-31	$11,425	500	0.0%	Shares	Sole	2022-04-22
2021-12-31	$13,805	500	0.0%	Shares	Sole	2022-01-21
2021-09-30	$13,925	500	—	Shares	Sole	2021-11-02
No filing history on record for this holder in this stock.